Catalysts for Accord Healthcare Inc
128 tracked
Apr 22, 2026
drug shortage
Atropine Sulfate Injection shortage — Hospira, Inc., a Pfizer Company
Accord Healthcare Inc
→
Apr 21, 2026
drug shortage
Dexmedetomidine Hydrochloride Injection shortage — Accord Healthcare Inc.
Accord Healthcare Inc
→
Apr 20, 2026
approval
DALFAMPRIDINE — FDA approval
dalfampridine ER
→
Apr 15, 2026
drug shortage
Clonazepam Tablet shortage — Accord Healthcare Inc.
Accord Healthcare Inc
→
Apr 15, 2026
drug shortage
Carboplatin Injection shortage — Accord Healthcare Inc.
Accord Healthcare Inc
→
Apr 15, 2026
drug shortage
Atropine Sulfate Injection shortage — Accord Healthcare Inc.
Accord Healthcare Inc
→
Apr 15, 2026
drug shortage
Methotrexate Sodium Injection shortage — Accord Healthcare Inc.
Accord Healthcare Inc
→
Mar 18, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 18, 2026
approval
VIGABATRIN — FDA approval
VIGABATRIN
→
Mar 17, 2026
approval
OXALIPLATIN — FDA approval
OXALIPLATIN
→
Mar 17, 2026
approval
OXALIPLATIN — FDA approval
OXALIPLATIN
→
Mar 13, 2026
approval
METHOTREXATE — FDA approval
Maxtrex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 4, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Feb 3, 2026
approval
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jan 26, 2026
approval
DAPTOMYCIN — FDA approval
Daptomycin Novo
→
Jan 7, 2026
approval
QUETIAPINE FUMARATE — FDA approval
quetiapine fumarate ER
→
Nov 25, 2025
approval
ACETAZOLAMIDE — FDA approval
Accord Healthcare Inc
→
Nov 14, 2025
approval
LENALIDOMIDE — FDA approval
LENALIDOMIDE
→
Nov 13, 2025
approval
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approval
ondansetron hydrochloride CR
→
Oct 28, 2025
approval
ENLON-PLUS (ATROPINE SULFATE) — FDA approval
Accord Healthcare Inc
→
Oct 28, 2025
approval
ENLON-PLUS (ATROPINE SULFATE) — FDA approval
Accord Healthcare Inc
→
Oct 3, 2025
approval
CLOMIPHENE CITRATE — FDA approval
CLOMIPHENE CITRATE
→
Oct 1, 2025
approval
LETROZOLE — FDA approval
LETROZOLE
→
Oct 1, 2025
approval
LETROZOLE — FDA approval
LETROZOLE
→
Oct 1, 2025
approval
DIAMOX (ACETAZOLAMIDE) — FDA approval
Accord Healthcare Inc
→
Jul 25, 2025
approval
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
May 29, 2025
approval
METHOTREXATE — FDA approval
Maxtrex
→
Feb 18, 2025
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→